Drug interactions
Basiliximab + Lisocabtagene maraleucel
Severity: Major
Basiliximab and Lisocabtagene maraleucel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Lisocabtagene maraleucel is a CAR T-cell therapy that depends on functional T-cell expansion, while basiliximab inhibits activated T cells through IL-2 receptor blockade. Combined use may reduce CAR T-cell efficacy and adds to infection risk in an already immunocompromised patient.
What this interaction means in plain words
Basiliximab and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Basiliximab belongs to Miscellaneous; Lisocabtagene maraleucel belongs to Oncology.
Why it happens
Basiliximab blocks CD25 on activated T cells, which may impair CAR T-cell proliferation and persistence, with additive immunosuppression.
What to do
Avoid basiliximab around CAR T-cell infusion unless essential, and choose alternative approaches where possible. If used, monitor closely for infection and for loss of CAR T-cell response.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Basiliximab and Lisocabtagene maraleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Basiliximab
- Basiliximab + Bcg vaccine live Contraindicated
- Basiliximab + Influenza virus vaccine quadrivalent intranasal Contraindicated
- Basiliximab + Measles mumps and rubella vaccine Contraindicated
- Basiliximab + Measles mumps and rubella vaccine live Contraindicated
- Basiliximab + Measles mumps rubella and varicella vaccine live Contraindicated
- Basiliximab + Measles vaccine Contraindicated
Other interactions of Lisocabtagene maraleucel
Frequently asked questions
Can I take Basiliximab with Lisocabtagene maraleucel?
MediHelp rates the interaction as major. Basiliximab and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lisocabtagene maraleucel is a CAR T-cell therapy that depends on functional T-cell expansion, while basiliximab inhibits activated T cells through IL-2 receptor blockade. Combined use may reduce CAR T-cell efficacy and adds to infection risk in an already immunocompromised patient.
How serious is the interaction between Basiliximab and Lisocabtagene maraleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid basiliximab around CAR T-cell infusion unless essential, and choose alternative approaches where possible. If used, monitor closely for infection and for loss of CAR T-cell response.
What other medicines interact with Basiliximab?
MediHelp also lists interactions of Basiliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Basiliximab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
